NasdaqGM - Delayed Quote USD
Exagen Inc. (XGN)
5.85
+0.13
+(2.27%)
At close: 4:00:00 PM EDT
5.98
+0.13
+(2.22%)
After hours: 6:12:22 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -0.21 | -0.12 | -0.54 | -0.26 |
| Low Estimate | -0.23 | -0.16 | -0.55 | -0.3 |
| High Estimate | -0.19 | -0.09 | -0.53 | -0.23 |
| Year Ago EPS | -0.19 | -0.16 | -0.83 | -0.54 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | 14.55M | 16.37M | 64.69M | 74.4M |
| Low Estimate | 14.5M | 15.5M | 63.9M | 73M |
| High Estimate | 14.7M | 17.05M | 66.1M | 75.2M |
| Year Ago Sales | 14.41M | 15.06M | 55.64M | 64.69M |
| Sales Growth (year/est) | 0.96% | 8.67% | 16.27% | 15.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.35 | -0.35 | -0.28 | -0.24 |
| EPS Actual | -0.19 | -0.16 | -0.28 | -0.2 |
| Difference | 0.16 | 0.19 | 0 | 0.04 |
| Surprise % | 45.71% | 53.96% | 1.75% | 16.67% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.21 | -0.12 | -0.54 | -0.26 |
| 7 Days Ago | -0.21 | -0.12 | -0.54 | -0.26 |
| 30 Days Ago | -0.24 | -0.17 | -0.73 | -0.45 |
| 60 Days Ago | -0.24 | -0.17 | -0.73 | -0.45 |
| 90 Days Ago | -0.24 | -0.18 | -0.72 | -0.45 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 3 | 3 | 2 |
| Up Last 30 Days | 2 | 3 | 3 | 2 |
| Down Last 7 Days | 1 | -- | -- | -- |
| Down Last 30 Days | 1 | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| XGN | -8.77% | 22.92% | 34.94% | 52.47% |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Upgrades & Downgrades
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 1/13/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 1/3/2025 |
| Maintains | Cantor Fitzgerald: Overweight to Overweight | 5/14/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 9/26/2023 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 8/22/2023 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 5/16/2023 |
Related Tickers
STIM Neuronetics, Inc.
4.2400
+1.19%
NOTV Inotiv, Inc.
1.9200
+8.47%
CRL Charles River Laboratories International, Inc.
115.76
+6.20%
MYGN Myriad Genetics, Inc.
7.37
+1.10%
VCYT Veracyte, Inc.
32.14
+2.15%
WGS GeneDx Holdings Corp.
109.39
+3.50%
CDNA CareDx, Inc
18.49
+3.64%
FLGT Fulgent Genetics, Inc.
19.04
+0.74%
GRAL GRAIL, Inc.
37.69
+11.64%
NEOG Neogen Corporation
5.20
+5.69%